
Launching in 2027, the Cell & Gene Therapy Insights Viral Vectors Special Interest Group (SIG) is an invitation-only initiative that brings senior experts together to build consensus, set priorities, and produce practical, open-access guidance for the field.
Interested in sponsoring the SIG?
Enquiry formViral vectors remain the delivery backbone of gene therapy, but the obstacles now sit across the full path from design to patient. In its inaugural year, this exclusive group will address these challenges under the Chatham House Rule in a series of focus groups, including:
Each focus group produces consensus statements that form the basis of the SIG’s outputs, which are then shared through Cell & Gene Therapy Insights’ network of 47,000 life sciences professionals.
Sponsoring puts your expert at the table where the field agrees what comes next for viral vectors, and your brand at the center of the solution.
your expert sits as an integral part of the conversation alongside leading voices from across the field.
at the core of every sponsorship is involvement in a focus group, giving you direct access to senior leaders.
the SIG is an independent, editorially led initiative of hand-picked experts, with market-leading outputs throughout the year.
each focus group produces consensus statements that form the basis of the SIG’s outputs, so your expert contributes to work that carries the weight of the group.
sponsorship of the SIG gives year-round exposure with multiple touchpoints.
Each SIG cycle turns closed-door discussion into published priorities
The Steering Committee leads discussion and prioritisation
Sponsor: your logo and link on the SIG website
Small groups of experts meet under the Chatham House Rule
Sponsor: your expert takes a seat in the group of your choice
Members agree priorities, practical solutions and future direction
Sponsor: your expert helps shape the agreed position
An open-access report sets out the agreed recommendations
Sponsor: your logo, link and expert listed in the report
Webinars, infographics and emails keep the SIG in view all year
Sponsor: your chosen package delivers the follow-on content
Outcomes shape the next round
Every package starts with your expert’s seat in a focus group, then sets how you take the outcomes to market. The team at BioInsights will work with you to find the best package for you based on your objectives.
Your expert carries the focus group’s conclusions to a live audience, alongside the key opinion leaders who shaped them. Your company is seen leading the conversation, not just taking part in it.
Best for: lead generation, people profiling, demonstrating expertise and networking
Complex conclusions become a clear, branded resource that people keep coming back to and pass on. Your brand becomes linked with making sense of the field’s hardest problems.
Best for: demonstrating expertise, brand awareness and networking
Following the published report, your content is delivered directly to an audience that is already engaged, not one you have to win over from scratch.
Best for: lead generation, brand awareness and networking
Alongside your expert’s place in a focus group, BioInsights runs an exclusive benchmarking research project, giving you original data on how the field compares.
Best for: launching new data, lead generation, brand awareness, demonstrating expertise and networking